1. Home
  2. FA vs XENE Comparison

FA vs XENE Comparison

Compare FA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FA
  • XENE
  • Stock Information
  • Founded
  • FA 2003
  • XENE 1996
  • Country
  • FA United States
  • XENE Canada
  • Employees
  • FA N/A
  • XENE N/A
  • Industry
  • FA Business Services
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FA Consumer Discretionary
  • XENE Health Care
  • Exchange
  • FA Nasdaq
  • XENE Nasdaq
  • Market Cap
  • FA 2.9B
  • XENE 2.4B
  • IPO Year
  • FA 2021
  • XENE 2014
  • Fundamental
  • Price
  • FA $16.06
  • XENE $39.21
  • Analyst Decision
  • FA Hold
  • XENE Strong Buy
  • Analyst Count
  • FA 6
  • XENE 11
  • Target Price
  • FA $20.75
  • XENE $52.73
  • AVG Volume (30 Days)
  • FA 778.4K
  • XENE 833.8K
  • Earning Date
  • FA 08-07-2025
  • XENE 08-11-2025
  • Dividend Yield
  • FA N/A
  • XENE N/A
  • EPS Growth
  • FA N/A
  • XENE N/A
  • EPS
  • FA N/A
  • XENE N/A
  • Revenue
  • FA $1,251,464,000.00
  • XENE $7,500,000.00
  • Revenue This Year
  • FA $84.37
  • XENE N/A
  • Revenue Next Year
  • FA $5.99
  • XENE $256.34
  • P/E Ratio
  • FA N/A
  • XENE N/A
  • Revenue Growth
  • FA 65.34
  • XENE N/A
  • 52 Week Low
  • FA $12.32
  • XENE $26.74
  • 52 Week High
  • FA $20.79
  • XENE $46.00
  • Technical
  • Relative Strength Index (RSI)
  • FA 43.88
  • XENE 67.80
  • Support Level
  • FA $15.63
  • XENE $38.13
  • Resistance Level
  • FA $16.61
  • XENE $39.84
  • Average True Range (ATR)
  • FA 0.51
  • XENE 0.99
  • MACD
  • FA -0.04
  • XENE -0.09
  • Stochastic Oscillator
  • FA 42.45
  • XENE 77.70

About FA First Advantage Corporation

First Advantage Corp is a provider of employment background screening and verification solutions. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment, which performs various background checks and compliance services across all phases of the workforce lifecycle, from pre-onboarding services to post-onboarding and ongoing monitoring services, covering employees, contractors, contingent workers, tenants, and drivers. The company delivers solutions across multiple industry verticals in the United States, Canada, and Latin America. Geographically, it derives key revenue from the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: